Cardioprotection provided by the different hypoglycaemic agents: key points
| • Exercise is an important part of the treatment |
| • Tight glucose control is essential |
| • Metformin decreases macrovascular complications in obese patients |
| • Sulfonylureas may have different impacts in cardioprotection |
| • Glitazones are important in the cardioprotection of patients without left ventricular dysfunction |